Market Recap Check: Zai Lab Limited ADR (ZLAB)’s Negative Finish at 36.43, Up/Down -2.31

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $36.43 in the last session, down -2.31% from day before closing price of $37.29. In other words, the price has decreased by -$2.31 from its previous closing price. On the day, 0.98 million shares were traded. ZLAB stock price reached its highest trading level at $36.48 during the session, while it also had its lowest trading level at $35.32.

Ratios:

We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.

On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.

On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Amado Rafael bought 7,541 shares for $35.89 per share.

Smiley Joshua L bought 11,740 shares of ZLAB for $421,398 on Apr 02 ’25. On Apr 02 ’25, another insider, Du Ying, who serves as the Officer of the company, bought 5,808 shares for $35.89 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 4031198208 and an Enterprise Value of 39492141056. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.97 while its Price-to-Book (P/B) ratio in mrq is 4.67. Its current Enterprise Value per Revenue stands at 98.981 whereas that against EBITDA is -146.126.

Stock Price History:

The Beta on a monthly basis for ZLAB is 1.02, which has changed by 1.3579288 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $39.77, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 12.65%, while the 200-Day Moving Average is calculated to be 43.18%.

Shares Statistics:

According to the various share statistics, ZLAB traded on average about 925.96K shares per day over the past 3-months and 1132590 shares per day over the past 10 days. A total of 109.14M shares are outstanding, with a floating share count of 108.11M. Insiders hold about 0.94% of the company’s shares, while institutions hold 51.10% stake in the company. Shares short for ZLAB as of 1741910400 were 7920858 with a Short Ratio of 8.55, compared to 1739491200 on 7577556. Therefore, it implies a Short% of Shares Outstanding of 7920858 and a Short% of Float of 8.33.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular